Here Are the Top 10 ASX 200 Shares Today
U.S. Tariffs Could Force Moves by Australian Med-Techs -- Market Talk
Will Weakness in Cochlear Limited's (ASX:COH) Stock Prove Temporary Given Strong Fundamentals?
Macquarie Upgrades Cochlear to Neutral From Underperform, Price Target Is AU$289
Cochlear Affirms Up to 11% Underlying Net Profit Growth Guidance for Fiscal 2025
With 51% Institutional Ownership, Cochlear Limited (ASX:COH) Is a Favorite Amongst the Big Guns
Cochlear (ASX:COH) Will Want To Turn Around Its Return Trends
Cochlear Shakes Bear on Revenue Growth Prospects -- Market Talk
Cochlear Target Price Raised 20% to A$305.00/Share by Citi>COH.AU
Cochlear Raised to Neutral From Sell by Citigroup >COH.AU
Cochlear (ASX:COH) Announces New CFO and Share Buyback Program, Signaling Strategic Growth Initiatives
Australian Healthcare Players See Wage Indexation Benefits, Margin Expansion in Fiscal 2025, Jarden Research Says
Why Is the Cochlear Share Price in the Red Today?
Cochlear Names New CFO
Healthy Aging Month | Daughter Helps Father Win Back His Livelihood With Cochlear Implant
Those Who Invested in Cochlear (ASX:COH) Five Years Ago Are up 48%
Cochlear 'Quality Franchise' Post-Fiscal 2024 Earnings, Jefferies Says
Cochlear Limited's (ASX:COH) Intrinsic Value Is Potentially 19% Below Its Share Price
First Sentier Becomes Substantial Holder in Cochlear Ltd
Jarden Research Adjusts Cochlear Limited's Price Target to AU$262.22 From AU$244.36, Keeps at Neutral
No Data
No Data